Workflow
Washington is primed to let Rivian and Lucid sell EVs directly to consumers
GeekWire· 2026-02-27 22:22
With the threat of a ballot initiative looming, a slate of auto dealers in Washington have come out in support of EV makers Rivian and Lucid Motors in their pursuit of direct sales to consumers. Electric automakers have fought for years to change the state law that only allows Tesla to directly sell cars, operate showrooms and offer test drives to potential customers in Washington. The rule exists to prevent manufacturers from competing against franchised dealerships. In December, Rivian began taking steps ...
JPMorgan Warns Up to $150 Billion of Loans in CLOs Face AI Risk
Yahoo Finance· 2026-02-27 22:21
Anywhere from $40 billion to $150 billion of leveraged loans packaged into US collateralized loan obligations could be disrupted by the artificial intelligence boom, according to JPMorgan Chase & Co. That’s because those loans fall within sectors most associated with AI risk, according to the Wall Street lender, which released its estimate as a recap of the SFVegas 2026 conference where software’s impact on corporate CLOs was “the topic du jour.” Most Read from Bloomberg CLOs offer investors exposure t ...
Schneider Electric: Now Significantly Overvalued Into 2026
Seeking Alpha· 2026-02-27 22:21
Core Viewpoint - The article emphasizes the importance of conducting thorough due diligence and research before making any investment decisions, highlighting that past performance does not guarantee future results [2][3]. Group 1 - The author does not hold any stock, options, or similar derivative positions in the companies mentioned and has no plans to initiate such positions in the near future [1]. - The article clarifies that it is not financial advice and that the author is not a licensed financial advisor, urging investors to understand the risks involved in various trading styles [2]. - It is noted that investing in European and non-US stocks may involve specific withholding tax risks, and investors are encouraged to consult tax professionals regarding these matters [2]. Group 2 - The article states that Seeking Alpha does not provide recommendations or advice on the suitability of investments for particular investors, and opinions expressed may not reflect the views of Seeking Alpha as a whole [3]. - The authors of the articles include both professional and individual investors, some of whom may not be licensed or certified by any regulatory body [3].
Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering
TMX Newsfile· 2026-02-27 22:21
Core Viewpoint - Sharp Therapeutics Corp. has successfully closed the first tranche of its non-brokered private placement for unsecured convertible notes, raising a total of US$500,000 through the issuance of 500 notes, with proceeds allocated for general working capital purposes [1]. Group 1: Note Offering Details - Each note has a principal amount of US$1,000 and is convertible into common shares at a price of US$2.00 per share, with a conversion option available until 12 months post-closing [2]. - The notes carry an interest rate of 6.0% per annum, calculated as simple interest and payable in cash on the maturity date [3]. - The first tranche included participation from insiders, with STX Partners, LLC acquiring 200 notes for US$200,000, Newlin Investment Company 1, LLC acquiring 100 notes for US$100,000, and others, totaling 350 notes for US$350,000 [4]. Group 2: Regulatory and Compliance Information - The insider participation in the first tranche is classified as a related-party transaction, exempt from formal valuation or minority shareholder approval under Multilateral Instrument 61-101, as the transaction does not exceed 25% of the company's market capitalization [5]. - The company did not file a material change report prior to the closing due to the timing of insider participation details, and no new Control Person will be created as a result of this tranche [6]. Group 3: Future Commitments and Offerings - STX has committed an additional US$800,000 for future contributions in four tranches of US$200,000 each, scheduled for March and April 2026 [7]. - The notes were offered through private placement in Canada and the United States, adhering to applicable exemptions from prospectus requirements [8]. Group 4: Company Overview - Sharp Therapeutics is a preclinical-stage company focused on developing small-molecule therapeutics for genetic diseases, utilizing a discovery platform that combines high throughput screening technologies and computationally optimized compound libraries [10].
Up Nearly 300% Since 2025, Is Applied Digital Stock a Buy?
Yahoo Finance· 2026-02-27 22:20
Applied Digital (NASDAQ: APLD) has been one of the best stock picks over the past year. It has risen nearly 300% since 2025 began, but it has sharply sold off over the past few weeks. Now, it's down nearly 30% from its all-time high established in January. Applied Digital has been a great stock to own over the past few months, but is now the time to buy? I think it could easily bounce back, especially once the market gets its appetite for artificial intelligence (AI) investing back. Will AI create the worl ...
Read the memo: David Ellison addresses staff as Paramount Skydance and Warner Bros. make it official
Business Insider· 2026-02-27 22:20
Paramount Skydance and Warner Bros. Discovery have made it official, and CEO David Ellison sent a memo out to staff about the merger.Paramount said in an official announcement on Friday that it had entered into a definitive merger agreement with Warner Bros. Discovery, giving the David Ellison-run media firm valuable assets such as HBO, CNN, and DC Studios.Netflix, which was also vying for WBD, declined to raise its bid for the company on Thursday.Read the memo Ellison sent:Team,Today we announced that Para ...
SmartCentres Real Estate Investment Trust Further Extends Arrangements with Penguin Group
Financialpost· 2026-02-27 22:19
Article contentSuch forward-looking statements involve significant risks and uncertainties. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including that the discussions between the parties could be unsuccessful; that the existing agreements could be terminated in accordance with their terms and that Mr. Goldhar does not remain with the Trust; that the terms of any amended, extended, supplemented or replaced definitive agreem ...
FS KKR Capital: Painful Dividend Cut, But Meaningful Discount To NAV Opens Up (NYSE:FSK)
Seeking Alpha· 2026-02-27 22:15
The equity market is a powerful mechanism as daily fluctuations in price get aggregated to incredible wealth creation or destruction over the long term. Pacifica Yield aims to pursue long-term wealth creation with a focus on undervalued yet high-growth companies, high-dividend tickers, REITs, and green energy firms.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote th ...
FS KKR Capital: Painful Dividend Cut, But Meaningful Discount To NAV Opens Up
Seeking Alpha· 2026-02-27 22:15
Core Viewpoint - The equity market serves as a significant mechanism for wealth creation or destruction over the long term, with Pacifica Yield focusing on undervalued high-growth companies, high-dividend stocks, REITs, and green energy firms [1] Group 1 - Pacifica Yield aims to pursue long-term wealth creation [1] - The strategy includes a focus on undervalued yet high-growth companies [1] - High-dividend tickers, REITs, and green energy firms are also part of the investment focus [1]
The Ultimate 8%-Yielding 'Sleep-Well-At-Night' Retirement Income Machine
Seeking Alpha· 2026-02-27 22:12
Core Insights - The portfolio's total return outperformance indicates a disciplined, income-focused strategy centered on high-conviction ideas trading at attractive discounts [1] Group 1: Investment Strategy - The ultimate retirement income machine aims to provide a high current yield to cover living expenses while ensuring sustainable long-term growth that meets or exceeds inflation [2] - High Yield Investor focuses on balancing safety, growth, yield, and value in its investment approach [2] Group 2: Team and Expertise - Samuel Smith, leading the High Yield Investor group, has a diverse background in dividend stock research and engineering, enhancing the team's analytical capabilities [2] - The team includes Jussi Askola and Paul R. Drake, who collaborate to identify optimal investment opportunities [2] Group 3: Service Offerings - High Yield Investor provides real-money core, retirement, and international portfolios, along with regular trade alerts and educational content [2] - An active chat room for like-minded investors is part of the service, fostering community engagement [2]